Trial Profile
A study of Herceptin (trastuzumab) in combination chemotherapy in patients with metastatic breast cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Feb 2010
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary) ; Cisplatin; Epirubicin; Paclitaxel
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Roche
- 13 Jun 2006 New trial record.